Safety and Efficacy of CD22 and CD19 Chimeric Antigen Receptor T Cell Treatment Bridging to Autologous Stem Cell Transplantation As Consolidation Therapy for B-Cell Acute Lymphoblastic Leukemia

被引:0
|
作者
Qiu, Yan [1 ]
Qian, Chong-Sheng [1 ]
Zhou, Hai-Xia [1 ]
Xu, Ming-Zhu [1 ]
Kang, Li-Qing [2 ]
Sun, Ai-Ning [1 ]
Wu, De-Pei [1 ]
Yu, Lei [2 ]
Xue, Shengli [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
关键词
D O I
10.1182/blood-2022-164636
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:10337 / 10338
页数:2
相关论文
共 50 条
  • [31] Efficacy and Safety of Autologous Stem Cell Transplantation Combined with Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Refractory/Relapsed B-Cell Lymphoma
    Ma, Lixia
    Ke, Xiaoyan
    Hu, Kai
    BLOOD, 2023, 142
  • [32] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
  • [33] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
    Rapoport, Aaron P.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
  • [34] CD19 and CD22-directed biespecific CAR for B-cell Acute Lymphoblastic Leukemia
    Zanetti, S. R.
    Velasco-Hernandez, T.
    Gutierrez-Aguera, F.
    Roca-Ho, H.
    Sanchez-Martinez, D.
    Petazzi, P.
    Torres, R.
    Molina, O.
    Torrebadell-Burriel, M.
    Vidriales-Vicente, M. B.
    Hrusak, O.
    Fuster, J. L.
    Juan, M.
    Bueno, C.
    Menendez, P.
    HUMAN GENE THERAPY, 2019, 30 (11) : A54 - A54
  • [35] A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia
    Hu, Yongxian
    Wang, Jiasheng
    Wei, Guoqing
    Yu, Jian
    Luo, Yi
    Shi, Jimin
    Wu, Wenjun
    Zhao, Kui
    Xiao, Lei
    Zhang, Yanlei
    Wu, Zhao
    Xu, Huijun
    Chang, Alex Hongsheng
    Huang, He
    BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1208 - 1217
  • [36] Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma
    Huang, Lefu
    Li, Jingjing
    Yang, Junfang
    Zhang, Xian
    Zhang, Min
    He, Jiujiang
    Zhang, Gailing
    Li, Wenqian
    Wang, Hui
    Li, Jianqiang
    Lu, Peihua
    CELLS, 2022, 11 (24)
  • [37] A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia
    Yongxian Hu
    Jiasheng Wang
    Guoqing Wei
    Jian Yu
    Yi Luo
    Jimin Shi
    Wenjun Wu
    Kui Zhao
    Lei Xiao
    Yanlei Zhang
    Zhao Wu
    Huijun Xu
    Alex Hongsheng Chang
    He Huang
    Bone Marrow Transplantation, 2019, 54 : 1208 - 1217
  • [38] CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell Lymphoma
    Jacobson, Caron A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 328 - +
  • [39] Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies
    Garcia-Prieto, Carlos A.
    Villanueva, Lorea
    Bueno-Costa, Alberto
    Davalos, Veronica
    Azucena Gonzalez-Navarro, Europa
    Juan, Manel
    Urbano-Ispizua, Alvaro
    Delgado, Julio
    Ortiz-Maldonado, Valentin
    Del Bufalo, Francesca
    Locatelli, Franco
    Quintarelli, Concetta
    Sinibaldi, Matilde
    Soler, Marta
    Castro de Moura, Manuel
    Ferrer, Gerardo
    Urdinguio, Rocio G.
    Fernandez, Agustin F.
    Fraga, Mario F.
    Bar, Diana
    Meir, Amilia
    Itzhaki, Orit
    Besser, Michal J.
    Avigdor, Abraham
    Jacoby, Elad
    Esteller, Manel
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (03): : 436 - 445
  • [40] CD19 regulates CD22 function in B cell development and B cell antigen receptor signal transduction
    Bradney, AP
    Fujimoto, M
    Poe, JC
    Tedder, TF
    FASEB JOURNAL, 1999, 13 (05): : A987 - A987